| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |